Yan Bi Selected Research

Liver Diseases (Liver Disease)

3/2019	Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice.
1/2016	Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Bi Research Topics

Disease

36	Type 2 Diabetes Mellitus (MODY) 04/2022 - 04/2008
28	Insulin Resistance 06/2022 - 12/2008
12	Inflammation (Inflammations) 04/2022 - 01/2010
12	Non-alcoholic Fatty Liver Disease 01/2022 - 02/2016
10	Pancreatitis 01/2022 - 08/2015
9	Weight Loss (Weight Reduction) 06/2022 - 09/2015
9	Body Weight (Weight, Body) 06/2022 - 01/2013
9	Obesity 06/2022 - 09/2009
6	Glucose Intolerance 01/2018 - 08/2011
5	Chronic Pancreatitis 10/2021 - 01/2019
5	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2021 - 07/2012
4	Overweight 06/2022 - 01/2018
4	Neoplasms (Cancer) 06/2022 - 10/2014
4	Schizophrenia (Dementia Praecox) 01/2022 - 09/2015
4	Hypoglycemia (Reactive Hypoglycemia) 06/2021 - 06/2012
4	Fibrosis (Cirrhosis) 01/2021 - 05/2014
4	Hyperglycemia 01/2021 - 01/2011
4	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 12/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2014
3	Cognitive Dysfunction 01/2022 - 01/2021
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 01/2018
3	Weight Gain 01/2020 - 06/2012
3	Diabetes Mellitus 03/2015 - 08/2012
2	Hypertension (High Blood Pressure) 06/2021 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 12/2020 - 01/2020
2	Heart Failure 01/2020 - 09/2018
2	Endotoxemia 01/2020 - 07/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020 - 11/2019
2	Liver Diseases (Liver Disease) 03/2019 - 01/2016
2	Hyperandrogenism 01/2019 - 01/2018
2	Mental Disorders (Mental Disorder) 01/2019 - 12/2016
2	Dyslipidemias (Dyslipidemia) 07/2018 - 01/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 05/2014 - 07/2013
2	Malaria 04/2012 - 06/2008
1	Adenocarcinoma 06/2022
1	Celiac Disease (Celiac Sprue) 06/2022
1	Bacterial Infections (Bacterial Infection) 01/2022

Drug/Important Bio-Agent (IBA)

24	Insulin (Novolin)FDA Link 06/2022 - 12/2008
19	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2010
10	Metformin (Glucophage)FDA LinkGeneric 06/2022 - 06/2015
9	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 04/2008
9	Blood Glucose (Blood Sugar)IBA 06/2021 - 01/2013
7	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2009
7	LipidsIBA 01/2021 - 08/2012
5	Insulin Glargine (Lantus)FDA Link 06/2021 - 01/2018
5	Hemoglobins (Hemoglobin)IBA 05/2021 - 06/2018
5	Erythropoietin FDA Link 08/2019 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
4	Liraglutide FDA Link 01/2022 - 08/2017
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 09/2018 - 06/2012
4	Exenatide (Byetta)FDA Link 06/2018 - 10/2014
4	Sterol Regulatory Element Binding Protein 1IBA 07/2017 - 03/2014
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2010
3	AndrogensIBA 03/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 03/2021 - 04/2012
3	CeruletideIBA 01/2021 - 01/2019
3	ProlactinIBA 01/2020 - 01/2018
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2020 - 12/2018
3	Gliclazide (Diamicron)IBA 03/2019 - 08/2012
3	ElementsIBA 06/2015 - 03/2014
3	SterolsIBA 06/2015 - 03/2014
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2021
2	NAD (NADH)IBA 09/2021 - 01/2021
2	LDL CholesterolIBA 05/2021 - 07/2018
2	CollagenIBA 12/2020 - 01/2019
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 05/2019
2	TrypsinIBA 01/2020 - 01/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 01/2018
2	TrypsinogenIBA 01/2020 - 01/2019
2	nasIBA 01/2020 - 10/2018
2	Biphasic InsulinsIBA 06/2019 - 06/2012
2	Neutralizing AntibodiesIBA 01/2019 - 05/2014
2	Testosterone (Sustanon)FDA Link 01/2018 - 01/2016
2	Phosphotransferases (Kinase)IBA 08/2017 - 10/2014
2	AMP-Activated Protein KinasesIBA 07/2017 - 06/2015
2	SilymarinIBA 01/2017 - 01/2016
2	pigment epithelium-derived factorIBA 09/2015 - 01/2013
2	acetovanillone (apocynin)IBA 01/2011 - 01/2010
2	CytokinesIBA 01/2009 - 12/2008
2	NF-kappa B (NF-kB)IBA 01/2009 - 12/2008
1	Glutens (Glutelin)IBA 06/2022
1	MLN 8237IBA 06/2022
1	Aurora Kinase AIBA 06/2022
1	glucagon-like peptide 1 (7-36)IBA 06/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2022
1	erucylphosphocholineIBA 04/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	dapagliflozinIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	LuciferasesIBA 01/2022

Therapy/Procedure

23	Therapeutics 04/2022 - 04/2008
8	Glycemic Control 06/2021 - 05/2010
4	Bariatric Surgery 05/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 06/2022 - 09/2015
2	Transplantation 01/2022 - 10/2021
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2021 - 01/2019